Total Payments
$181,754
2024 Payments
$11,343
Companies
47
Transactions
661
Medicare Patients
2,331
Medicare Billing
$519,927
Payment Breakdown by Category
Other$120,416 (66.3%)
Consulting$21,108 (11.6%)
Travel$19,877 (10.9%)
Food & Beverage$15,894 (8.7%)
Research$4,287 (2.4%)
Education$172.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,591 | 61 | 65.8% |
| Consulting Fee | $21,108 | 11 | 11.6% |
| Travel and Lodging | $19,877 | 66 | 10.9% |
| Food and Beverage | $15,894 | 485 | 8.7% |
| Unspecified | $4,287 | 30 | 2.4% |
| Honoraria | $825.00 | 2 | 0.5% |
| Education | $172.50 | 6 | 0.1% |
Payments by Type
General
$177,468
631 transactions
Research
$4,287
30 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $55,448 | 95 | $0 (2024) |
| GlaxoSmithKline, LLC. | $40,063 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32,838 | 119 | $0 (2024) |
| Genentech USA, Inc. | $20,758 | 47 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $10,145 | 24 | $0 (2020) |
| PFIZER INC. | $9,306 | 25 | $0 (2023) |
| SANOFI US SERVICES INC. | $3,154 | 26 | $0 (2023) |
| GENZYME CORPORATION | $1,854 | 51 | $0 (2024) |
| LEO Pharma AS | $1,133 | 4 | $0 (2018) |
| ALK-Abello, Inc | $1,074 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,343 | 65 | Novartis Pharmaceuticals Corporation ($7,722) |
| 2023 | $14,574 | 99 | GlaxoSmithKline, LLC. ($8,789) |
| 2022 | $31,262 | 81 | GlaxoSmithKline, LLC. ($16,632) |
| 2021 | $33,266 | 86 | Genentech USA, Inc. ($18,764) |
| 2020 | $9,038 | 61 | GlaxoSmithKline, LLC. ($4,316) |
| 2019 | $23,629 | 71 | Novartis Pharmaceuticals Corporation ($19,128) |
| 2018 | $34,869 | 114 | Novartis Pharmaceuticals Corporation ($13,651) |
| 2017 | $23,775 | 84 | Novartis Pharmaceuticals Corporation ($10,410) |
All Payment Transactions
661 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | LEO Pharma Inc. | — | Food and Beverage | In-kind items and services | $35.42 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $37.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Immunology and Neurology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.86 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: BIOLOGIC | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Immunology and Neurology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: Immunology | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $135.38 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $4,887.50 | General |
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $53.32 | General |
| Category: Respiratory | ||||||
| 10/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $83.59 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/24/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $132.40 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/24/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $105.60 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $64.07 | General |
| 10/21/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.07 | General |
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma | SANOFI US SERVICES INC. | $1,671 | 12 |
| Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are nave to, Intolerant of, or Incomplete Responders to Om | SANOFI US SERVICES INC. | $1,482 | 14 |
| TRALOKINUMAB TRIAL IN ADJUNCT SETTING | LEO Pharma AS | $1,133 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 498 | 4,550 | $247,025 | $106,134 |
| 2022 | 16 | 619 | 5,667 | $286,462 | $123,736 |
| 2021 | 14 | 635 | 7,084 | $349,638 | $158,219 |
| 2020 | 16 | 579 | 6,089 | $313,318 | $131,837 |
Total Patients
2,331
Total Services
23,390
Medicare Billing
$519,927
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 11 | 1,935 | $116,100 | $58,936 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 155 | $42,625 | $13,200 | 31.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 31 | 858 | $13,728 | $8,641 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 130 | $16,250 | $7,992 | 49.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 103 | $7,725 | $5,323 | 68.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 76 | 380 | $15,200 | $2,839 | 18.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 70 | 145 | $14,500 | $2,643 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,131 | $2,545 | 41.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 16 | 573 | $4,011 | $1,554 | 38.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 51 | 96 | $3,840 | $1,212 | 31.6% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 18 | 140 | $4,900 | $911.16 | 18.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $2,015 | $338.40 | 16.8% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 19 | 2,400 | $144,000 | $71,137 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 140 | $38,500 | $11,906 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 172 | $21,500 | $10,277 | 47.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 35 | 785 | $12,560 | $8,077 | 64.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 22 | 88 | $6,588 | $4,861 | 73.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 79 | 426 | $17,040 | $3,075 | 18.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 26 | 984 | $6,888 | $2,894 | 42.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 69 | 138 | $13,800 | $2,444 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,026 | $2,248 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $4,200 | $2,194 | 52.2% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 58 | 103 | $4,120 | $1,279 | 31.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 14 | 205 | $2,460 | $1,266 | 51.4% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 23 | 142 | $4,970 | $841.65 | 16.9% |
About Dr. John Ramey, MD
Dr. John Ramey, MD is a Allergy & Immunology healthcare provider based in North Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841260874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ramey, MD has received a total of $181,754 in payments from pharmaceutical and medical device companies, with $11,343 received in 2024. These payments were reported across 661 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,591).
As a Medicare-enrolled provider, Ramey has provided services to 2,331 Medicare beneficiaries, totaling 23,390 services with total Medicare billing of $519,927. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location North Charleston, SC
- Active Since 01/24/2006
- Last Updated 11/17/2015
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1841260874
Products in Payments
- NUCALA (Biological) $39,400
- XOLAIR (Biological) $28,982
- Xolair (Biological) $20,822
- FASENRA (Drug) $14,387
- FASENRA (Biological) $13,883
- NIOX VERO DEVICE (Device) $9,983
- EUCRISA (Drug) $9,187
- DUPIXENT (Biological) $5,378
- GILENYA (Drug) $1,293
- TEZSPIRE (Biological) $744.51
- Hizentra (Biological) $372.28
- AYVAKIT (Drug) $275.37
- Odactra (Drug) $259.01
- ORLADEYO (Drug) $234.28
- TRELEGY ELLIPTA (Drug) $213.20
- CINQAIR (Drug) $187.90
- ADBRY (Biological) $175.40
- Xhance (Drug) $174.76
- XOLAIR (Drug) $172.51
- Auvi-Q (Drug) $170.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in North Charleston
Dr. Allen Kaplan, M.d.m.d, M.D.M.D
Allergy & Immunology — Payments: $319,198
Allergy & Immunology $319,198
Dr. Ned Rupp, M.d, M.D
Allergy & Immunology — Payments: $187,402
Allergy & Immunology $187,402
Dr. Patricia Gerber, M.d, M.D
Allergy & Immunology — Payments: $19,639
Allergy & Immunology $19,639
Dr. Frederick Schaffer, M.d, M.D
Allergy & Immunology — Payments: $55.00
Allergy & Immunology $55.00
Dr. Allan Lieberman, M.d, M.D
Allergy & Immunology — Payments: $15.19
Allergy & Immunology $15.19
Dr. Albert Finn, M.d, M.D
Allergy & Immunology
Allergy & Immunology